TrialCirculation2015

Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.

Matthew A Cavender et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.